Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6748c1fba1292abba86450fa886727c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4483b7dcfa169d7ea8a61300461c0b4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ab11a1b5f20eacb76ac79edbf91989 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76826334cdde3e817c3aa08680b83d83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01254efc1073ff90fa67f197ad0b4da3 |
publicationDate |
2022-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022155274-A1 |
titleOfInvention |
Methods of predicting progression of neurological disease |
abstract |
The disclosure provides for methods of predicting disease progression comprising detecting a modification of one or more disease markers in a glial cell or neuronal cell generated from a skin cell of the subject. The disclosed methods include methods of identifying subjects that are responsive to a therapeutic agent and methods of determining effectiveness of a therapeutic agent. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110408594-A |
priorityDate |
2021-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |